Hemispherx BioPharma (HEB)

[PICKALITTLE]

I have now read the Thompson Reuter report and the Arrowhead report and two years of PRs. I feel much better about this company. The current dilution might hold this down in the short term but it is nearing an end and its going to an immediate cash generating project. In two years this will be a 2 dollar stock and if anything real happens with Ampligen 4 to 10 dollars is possible. IMO buy.